. 2020 Jan 24;6(1):34–40. doi: 10.1016/j.wjorl.2019.05.001

Table 5.

Relationship between the expressions of MAPK10, c-Jun and Itga6 and clinicopathological parameters[n].

Clinicopathological parameters	Cases(n)	MAPK10		χ²/U value	P value	c-Jun		χ²/U value	P value	Itga6		χ²/U value	P value
Clinicopathological parameters	Cases(n)	+	–	χ²/U value	P value	+	–	χ²/U value	P value	+	–	χ²/U value	P value
Age
≥60	22	17	5	0.060	0.529	20	2	0.236	0.503	17	5	0.065	0.799
<60	35	28	7	0.060	0.529	33	2	0.236	0.503	26	9	0.065	0.799
Gender
Male	45	33	12	0.0140	0.907	37	8	0.008	0.928	31	14	0.173	0.681
Female	12	9	3	0.0140	0.907	10	2			9	3
Clinical staging
Stage Ⅱ	30	28	1	9.411	0.005	36	0	7.375	0.015	23	13	7.035	0.010
Stage Ⅲ+stage Ⅳ	27	17	11	9.411	0.005	17	4	7.375	0.015	20	1	7.035	0.010
Pathological grading
High	20	19	1	−2.485	0.013	20	0	−2.650	0.006	11	9	−2.445	0.017
Moderate	28	21	7			27	1			24	4
Low	9	5	4			6	3			8	1
Tumor diameter
<3 cm	29	22	7	0.338	0.561	27	2	0.001	1.000	22	7	0.006	0.940
≥3 cm	28	23	5	0.338	0.561	26	2	0.001	1.000	21	7	0.006	0.940
Lymphnode metastasis
Yes	20	11	9	10.631	0.001	20	0	2.325	0.286	19	1	6.363	0.012
No	37	34	3	10.631	0.001	33	4	2.325	0.286	24	13	6.363	0.012